Subgroup Analysis in Clinical Trials ENAR 2012

From MultXpert

Jump to: navigation, search

Selected presentations given at the ENAR Conference in Washington, DC on April 2-4, 2012.

Key statistical considerations for clinical trials with tailoring objectives

Presented by Alex Dmitrienko, Executive Director, Quintiles (jointly with Brian Millen, Eli Lilly and Company).

Download slides.

Multiplicity considerations for hypotheses testing for a targeted subgroup trial design

Presented by Mohammad Huque, Director, Division of Biometrics IV, Office of Biostatistics, Office of the Translational Sciences, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration.

Download slides.